Gilead Sciences Inc Share Price
NASDAQ: GILDHealthcare
Live Gilead Sciences Inc Share Price Chart
O H L
Gilead Sciences Inc Performance Overview
Days Range
▼
$145.44Low
$148.50High
Markets Today
| Previous Close | $144.23 |
|---|---|
| Open | $145.64 |
| Volume | 1,894,858 |
| Day's Range | $145.44 - $148.50 |
| 52W Range | $112.41 - $157.29 |
| Market Cap | $179.33 B |
Historical Performance
| 1M Returns | -1.64 |
|---|---|
| 3M Returns | +5.77 |
| 6M Returns | +3.91 |
| 1Y Returns | +23.51 |
| 5Y Returns | +111.67 |
| 10Y Returns | +91.69 |
Gilead Sciences Inc Fundamentals
| Market Cap | $179.33 B |
|---|---|
| Dividend yield | 2.27 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $29.44 B |
| ROE TTM | 0.40 |
| EPS TTM | $-2.65 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 15.17 |
| EBITDA | $14.40 B |
| Profit Margin | 28.90 |
| Market Cap | $179.33 B |
|---|---|
| Dividend yield | 2.27 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $29.44 B |
| ROE TTM | 0.40 |
| EPS TTM | $-2.65 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 15.17 |
| EBITDA | $14.40 B |
| Profit Margin | 28.90 |
Gilead Sciences Inc Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $6.67 B | $7.08 B | $7.77 B | $7.92 B | $6.96 B | $7.80 B |
| Gross Profit + | $5.13 B | $5.58 B | $6.20 B | $6.30 B | $5.51 B | $6.22 B |
| Operating Income | $2.24 B | $2.47 B | $3.33 B | $1.98 B | $2.58 B | -$10.39 B |
| EBITDA | $3.19 B | $3.35 B | $4.18 B | $3.61 B | $3.38 B | -$7.95 B |
| Interest Expense | -$260.00 M | -$254.00 M | -$256.00 M | -$255.00 M | -$240.00 M | -$247.00 M |
| Depreciation | $949.00 M | $881.00 M | $856.00 M | $1.63 B | $796.00 M | $2.45 B |
| Income Before Tax | $1.65 B | $2.43 B | $3.64 B | $2.08 B | $2.58 B | -$10.25 B |
| Income Tax Expense | $334.00 M | $468.00 M | $589.00 M | -$105.00 M | $559.00 M | $242.00 M |
| Net Income + | $1.31 B | $1.96 B | $3.05 B | $2.18 B | $2.02 B | -$10.50 B |
| Net Profit Margin | 19.72% | 27.69% | 39.28% | 27.55% | 29.04% | -134.51% |
Gilead Sciences Inc Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $1.00 M | $1.00 M | $1.00 M | $1.00 M | $1.00 M | $1.00 M |
| Reserve & Surplus | $11.02 B | $11.31 B | $12.86 B | $13.77 B | $14.21 B | $2.29 B |
| Non-Current Liabilities | $25.01 B | $24.94 B | $24.78 B | $24.59 B | $23.37 B | $26.60 B |
| Current Liabilities | $12.34 B | $11.19 B | $12.30 B | $11.81 B | $9.48 B | $11.02 B |
| Total Liabilities | $37.36 B | $36.13 B | $37.08 B | $36.41 B | $32.85 B | $37.62 B |
| Fixed Assets | $24.78 B | $24.02 B | $23.47 B | $22.58 B | $22.02 B | $19.86 B |
| Current Assets | $16.90 B | $14.72 B | $17.87 B | $18.34 B | $18.64 B | $13.95 B |
| Total Assets | $56.43 B | $55.72 B | $58.53 B | $59.02 B | $56.28 B | $49.36 B |
Gilead Sciences Inc Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | $1.31 B | $1.96 B | $3.05 B | $2.18 B | $2.02 B | -$10.50 B |
| Operating Cash Flow | $1.76 B | $827.00 M | $4.11 B | $3.33 B | $2.54 B | $3.57 B |
| Investing Cash Flow | -$416.00 M | -$2.12 B | -$426.00 M | -$1.84 B | $1.77 B | -$10.35 B |
| Financing Cash Flow | -$3.43 B | -$1.57 B | -$1.49 B | -$1.26 B | -$4.24 B | $2.34 B |
| Change in Cash | -$2.06 B | -$2.78 B | $2.19 B | $233.00 M | $65.00 M | -$4.45 B |
Gilead Sciences Inc Peer Comparison
| Company | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|
 | $127.62B | 179.03% | 29.30 | 32.94% | 0.00% |
 | $156.23B | -35.66% | 36.25 | 12.48% | 6.28% |
 | $469.63B | 140.54% | 75.17 | 6.92% | 2.60% |
 | $81.13B | -39.40% | 0.00 | -145.16% | 0.00% |
 | $344.27B | 73.22% | 111.45 | 28.09% | 2.44% |
 | $74.79B | 33.82% | 17.78 | 31.41% | 0.52% |
 | $217.86B | 92.52% | 25.03 | 20.98% | 2.50% |
 | $6.12B | 128.87% | 32.63 | 46.42% | 0.00% |
 | $1.99B | -66.44% | 0.00 | -638.87% | 0.00% |
 | $120.13B | 0.98% | 12.95 | 14.64% | 4.29% |
Gilead Sciences Inc Return Calculator
The Gilead Sciences Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$21,578
Invested Amount$10,000
Est. Returns$11,578
About Gilead Sciences Inc
Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).
Popular Stocks
FAQs
What is the share price of Gilead Sciences Inc today?
Gilead Sciences Inc (GILD) share price as of October 7, 2026 is $147.03. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Gilead Sciences Inc?
Yes, Indian Investors can invest in the Gilead Sciences Inc (GILD) Share by opening an international trading account with Angel One.
How can I purchase Gilead Sciences Inc shares in India?
Purchasing Gilead Sciences Inc (GILD) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Gilead Sciences Inc (GILD) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Gilead Sciences Inc?
Yes, you can purchase fractional shares of Gilead Sciences Inc (GILD) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Gilead Sciences Inc?
The market capitalization of Gilead Sciences Inc on October 7, 2026, is $179.33 B.
In which sector Gilead Sciences Inc belongs?
Gilead Sciences Inc operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Gilead Sciences Inc stocks?
In order to invest in Gilead Sciences Inc (GILD) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
